AGA
PRQR icon

Altrinsic Global Advisors’s ProQR Therapeutics PRQR Stock Holding History

Altrinsic Global Advisors’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-321,360
Closed -$2.57M – 69
2021
Q4 		$2.57M Hold
321,360
– – 0.08% 55
2021
Q3 		$2.69M Hold
321,360
– – 0.08% 59
2021
Q2 		$2.17M Hold
321,360
– – 0.07% 63
2021
Q1 		$2.12M Buy
321,360
+80,000
+33% +$409K 0.07% 65
2020
Q4 		$1.01M Buy
241,360
+20,000
+9% +$84.4K 0.03% 73
2020
Q3 		$1.06M Hold
221,360
– – 0.04% 69
2020
Q2 		$1.35M Hold
221,360
– – 0.06% 65
2020
Q1 		$1.22M Hold
221,360
– – 0.07% 62
2019
Q4 		$2.19M Buy
221,360
+20,000
+10% +$156K 0.09% 54
2019
Q3 		$1.16M Hold
201,360
– – 0.05% 66
2019
Q2 		$1.83M Buy
201,360
+2,300
+1% +$27.1K 0.08% 58
2019
Q1 		$2.76M Buy
199,060
+17,700
+10% +$264K 0.13% 49
2018
Q4 		$2.86M Sell
181,360
-10,000
-5% -$184K 0.14% 51
2018
Q3 		$3.7M Hold
191,360
– – 0.17% 50
2018
Q2 		$1.4M Hold
191,360
– – 0.06% 69
2018
Q1 		$588K Hold
191,360
– – 0.02% 79
2017
Q4 		$617K Hold
191,360
– – 0.02% 81
2017
Q3 		$928K Hold
191,360
– – 0.04% 74
2017
Q2 		$995K Hold
191,360
– – 0.04% 78
2017
Q1 		$957K Sell
191,360
-19,196
-9% -$84.4K 0.03% 76
2016
Q4 		$1.03M Hold
210,556
– – 0.04% 75
2016
Q3 		$1.4M Buy
210,556
+5,556
+3% +$30.6K 0.05% 70
2016
Q2 		$992K Hold
205,000
– – 0.03% 74
2016
Q1 		$1M Hold
205,000
– – 0.03% 76
2015
Q4 		$1.78M Buy
205,000
+100,000
+95% +$1.15M 0.05% 75
2015
Q3 		$1.53M Buy
105,000
+7,110
+7% +$119K 0.04% 75
2015
Q2 		$1.63M Buy
97,890
+44,454
+83% +$837K 0.03% 78
2015
Q1 		$1.17M Buy
+53,436
New +$1.1M 0.03% 76

Other funds holding PRQR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Altrinsic Global Advisors's PRQR Position: Q1 2022 in Review

Altrinsic Global Advisors sold out of ProQR Therapeutics (PRQR) in Q1 2022, closing a stake of 321,360 shares — an estimated $2.57M sold.

Altrinsic Global Advisors first reported a position in PRQR in Q1 2015 and held it in 28 quarters. The position peaked at $3.7M in Q3 2018. 58 funds tracked by Wall St. Rank hold PRQR as of Q1 2022.

  • Altrinsic Global Advisors reported no remaining ProQR Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Altrinsic Global Advisors sold 321,360 ProQR Therapeutics shares in Q1 2022, an estimated $2.57M.
  • Altrinsic Global Advisors first reported a position in ProQR Therapeutics in Q1 2015 and held it in 28 quarters.
  • Altrinsic Global Advisors's ProQR Therapeutics position peaked at $3.7M in Q3 2018.
  • 58 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q1 2022.

Based on Altrinsic Global Advisors's 13F filing for Q1 2022, filed 16 May 2022.